Dudediligence.

Bristol-Myers Squibb Company

BMYNYSE · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$2,287,893

3 notices · 36,749 sh

Oct 2025 to Oct 2026

Reported ·

$1,850,016

2 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 2 reported sales carry the 10b5-1 box. Together they are under 0.01% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-09: Massacesi Cristian, Form 1442026-08-25: Holzer Phil M, Form 1442026-04-01: Elkins David V, Form 1442026-04-01: Elkins David V, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-09Massacesi Cristian, EVP,Chief Med Offr,Head of Dev$403,498
6,249 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-25Holzer Phil M, SVP and Controller$33,750
500 shno plan dateForm 4s on file end Jun 23144 ↗
2026-04-01Elkins David V, EVP, Chief Financial Officer$1,850,645
30,000 shplan 2025-06-03144 ↗
Form 4, 2026-04-02: sold 30,000 at $61.67 Form 4 ↗